Stock Earnings

Question 1

Takeda Pharmaceutical Co Ltdの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Takeda Pharmaceutical Co Ltdの総資産は$14,248,344で、純profitは$107,928です。

Question 2

TKPHFの主要な財務比率は何ですか？

Accepted Answer

Takeda Pharmaceutical Co Ltdの流動比率は1.94、純利益率は2.35、1株当たり売上高は$2,901.78です。

Question 3

Takeda Pharmaceutical Co Ltdの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Takeda Pharmaceutical Co Ltd largest revenue segment is Gastroenterology Revenue (Pre-FY2023 Reporting), at a revenue of 1,216,207,000,000 in the most earnings release.For geography, Japan is the primary market for Takeda Pharmaceutical Co Ltd, at a revenue of 418,462,000,000.

Question 4

Takeda Pharmaceutical Co Ltdは収益を上げていますか？

Accepted Answer

yes、最新の財務諸表によると、Takeda Pharmaceutical Co Ltdの純profitは$107,928です。

Question 5

Takeda Pharmaceutical Co Ltdに負債はありますか？

Accepted Answer

yes、Takeda Pharmaceutical Co Ltdの負債は7,313,260です。

Question 6

Takeda Pharmaceutical Co Ltdの発行済株式数は何株ですか？

Accepted Answer

Takeda Pharmaceutical Co Ltdの総発行済株式数は1,573.64株です。

Breakdown	TTM	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021
Revenue	4,417,004	4,581,551	4,263,762	4,027,478	3,569,006	3,197,812
Revenue Growth (YoY)	-3%	7%	6%	13%	12%	-3%
Cost of Revenue	1,563,688	1,580,217	1,426,678	1,244,072	1,106,846	994,308
Gross Profit	2,853,316	3,001,334	2,837,084	2,783,406	2,462,160	2,203,504
Selling, General & Admin	1,075,890	1,104,766	1,053,819	997,309	886,361	875,663
Research & Development	691,573	730,227	729,924	633,325	526,087	455,833
Operating Expenses	2,479,739	2,464,303	2,406,297	2,232,511	1,916,672	1,867,782
Other Non Operating Income (Expenses)	1	0	1	--	1	--
Pretax Income	97,912	175,084	52,791	375,090	302,571	366,235
Income Tax Expense	64,625	66,941	-91,406	58,052	72,405	-9,936
Net Income	33,075	107,928	144,067	317,017	230,059	376,005
Net Income Growth	-89%	-25%	-55%	38%	-39%	750%
Shares Outstanding (Diluted)	1,577.46	1,578.87	1,564.45	1,569.87	1,577.16	1,573.53
Shares Change (YoY)	-2%	1%	0%	0%	0%	0%
EPS (Diluted)	20.96	68.35	92.08	201.93	145.86	238.95
EPS Growth	-88%	-26%	-54%	38%	-39%	746%
Free Cash Flow	922,298	709,341	235,614	343,467	937,068	774,463
Free Cash Flow Per Share	584.67	449.27	150.6	218.78	594.14	492.17
Gross Margin	64.59%	65.5%	66.53%	69.11%	68.98%	68.9%
Operating Margin	8.45%	11.72%	10.1%	13.67%	15.28%	10.49%
Profit Margin	0.74%	2.35%	3.37%	7.87%	6.44%	11.75%
Free Cash Flow Margin	20.88%	15.48%	5.52%	8.52%	26.25%	24.21%
EBITDA	1,116,919	1,100,500	952,312	1,093,338	1,018,403	757,586
EBITDA Margin	25.28%	24.02%	22.33%	27.14%	28.53%	23.69%
D&A For EBITDA	743,342	563,469	521,525	542,443	472,915	421,864
EBIT	373,577	537,031	430,787	550,895	545,488	335,722
EBIT Margin	8.45%	11.72%	10.1%	13.67%	15.28%	10.49%
Effective Tax Rate	66%	38.23%	-173.14%	15.47%	23.92%	-2.71%

Takeda Pharmaceutical Co Ltd (TKPHF) Price

TKPHF Stock Price Chart

TKPHF Income

Follow-Up Questions